0.022
price down icon17.91%   -0.0048
 
loading
Precedente Chiudi:
$0.0268
Aprire:
$0.0214
Volume 24 ore:
52,518
Relative Volume:
12.59
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
$-43.29M
Rapporto P/E:
-0.02
EPS:
-1.1
Flusso di cassa netto:
$-34.80M
1 W Prestazione:
-86.50%
1M Prestazione:
-94.35%
6M Prestazione:
-97.62%
1 anno Prestazione:
-98.31%
Intervallo 1D:
Value
$0.0214
$0.0269
Intervallo di 1 settimana:
Value
$0.0214
$0.0269
Portata 52W:
Value
$0.0214
$0.0269

Viracta Therapeutics Inc Stock (VIRX) Company Profile

Name
Nome
Viracta Therapeutics Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
VIRX's Discussions on Twitter

Confronta VIRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VIRX
Viracta Therapeutics Inc
0.022 0 0 -43.29M -34.80M -1.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 26.46B 3.81B -644.79M -669.77M -6.24

Viracta Therapeutics Inc Stock (VIRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-16 Downgrade Leerink Partners Outperform → Market Perform
2022-02-01 Iniziato RBC Capital Mkts Outperform
2021-05-03 Iniziato H.C. Wainwright Buy
2021-04-26 Iniziato SVB Leerink Outperform
2021-03-25 Iniziato Evercore ISI Outperform

Viracta Therapeutics Inc Borsa (VIRX) Ultime notizie

pulisher
Mar 28, 2025

Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace

Mar 28, 2025
pulisher
Feb 27, 2025

Viracta Therapeutics (VIRX) to Release Quarterly Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 16, 2025

Calif. biotech company once worth $476M lays off every remaining employee - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Viracta Therapeutics, Inc. (NASDAQ:VIRX) Sees Significant Decrease in Short Interest - Defense World

Feb 16, 2025
pulisher
Feb 16, 2025

Semler Scientific (SMLR) Projected to Post Earnings on Tuesday - Defense World

Feb 16, 2025
pulisher
Feb 12, 2025

Viracta Therapeutics to cease operations and seek alternatives - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Finance Watch: Third Harmonic, Q32 Bio Cut Jobs To Focus On Lead Assets - insights.citeline.com

Feb 12, 2025
pulisher
Feb 10, 2025

Procaps Group (NASDAQ:PROC) vs. Viracta Therapeutics (NASDAQ:VIRX) Financial Comparison - Defense World

Feb 10, 2025
pulisher
Feb 09, 2025

🔬 Latest pharma industry updates 👇 - substack.com

Feb 09, 2025
pulisher
Feb 09, 2025

VIRX stock plunges to 52-week low, touches $0.08 - MSN

Feb 09, 2025
pulisher
Feb 07, 2025

Viracta Therapeutics Terminates Employees & Winds Down Operations - Contract Pharma

Feb 07, 2025
pulisher
Feb 07, 2025

Fierce Biotech Layoff Tracker 2025: Viracta shuts down; Layoffs hit Frontier - Fierce Biotech

Feb 07, 2025
pulisher
Feb 06, 2025

Viracta Winds Down Business, Unable to Weather Financial Troubles - BioSpace

Feb 06, 2025
pulisher
Feb 06, 2025

Viracta Therapeutics Announces Wind Down of Operations - GlobeNewswire

Feb 06, 2025
pulisher
Feb 06, 2025

Viracta Therapeutics to cease operations and seek alternatives By Investing.com - Investing.com South Africa

Feb 06, 2025
pulisher
Feb 05, 2025

Viracta Therapeutics Announces Wind Down Of Operations -February 05, 2025 at 06:39 pm EST - Marketscreener.com

Feb 05, 2025
pulisher
Feb 05, 2025

Viracta Therapeutics hits end of the line, laying off all workers and winding down - Fierce Biotech

Feb 05, 2025
pulisher
Feb 05, 2025

Viracta Therapeutics Announces Wind-Down and Leadership Changes - TipRanks

Feb 05, 2025
pulisher
Feb 05, 2025

Viracta Therapeutics Winds Down Operations, Terminates Employees - MarketWatch

Feb 05, 2025
pulisher
Feb 04, 2025

Leerink Partners slashes price target on Viracta Therapeutics Inc [VIRX] – find out why. - The DBT News

Feb 04, 2025
pulisher
Feb 04, 2025

Views of Wall Street’s Leading Experts on Viracta Therapeutics Inc - SETE News

Feb 04, 2025
pulisher
Feb 03, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

VIRX’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 03, 2025
pulisher
Feb 03, 2025

Analyzing VIRX’s price-to-book ratio for the last quarter - US Post News

Feb 03, 2025
pulisher
Feb 03, 2025

Viracta Therapeutics to be delisted from Nasdaq - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews

Feb 03, 2025
pulisher
Feb 03, 2025

Why Triumph Group Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 03, 2025

Viracta Therapeutics Inc Azioni (VIRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):